About
Clal Biotechnology Industries is a life sciences investment company. CBI is focused on identifying and supporting promising innovative ventures, developing proprietary solutions, addressing unmet medical needs with multibillion-dollar market potential. Clal Biotechnology Industries provides its companies access to the global biotechnology industry. Clal Biotechnology Industries invests in companies ranging from seed to maturity, both public and private. It applies diverse models of strategic cooperation, providing significant investments together with hands-on leadership and guidance. CBIs investments range from biotech and pharma to diagnostics and medical devices. Its team maximizes the value of existing investments, contributes to the development of investee companies and finds new investments and business opportunities with great potential returns in Israel and the United States. CBI's stockholders are Clal Industries, which holds a portfolio of investments from heavy industry to biotechnology, hi-tech and energy companies. Clal Industries is fully owned by Access Industries, a privately-held industrial group with long-term holdings in the sectors of natural resources and chemical, media and telecommunications, venture capital and real estate
Portfolio · 18
Investment activity
6 portfolio exits on record.
Portfolio by sector
Q&A
- What is Clal Biotechnology Industries' (CBI) primary investment focus?
- Clal Biotechnology Industries (CBI) is a life sciences investment company focused on identifying and supporting innovative ventures developing proprietary solutions for unmet medical needs. Their investments range from biotech and pharma to diagnostics and medical devices.
- Which sectors does Clal Biotechnology Industries (CBI) primarily invest in?
- Clal Biotechnology Industries (CBI) primarily invests in the Health Tech & Life Sciences sector, with 13 portfolio companies in this area. They also have investments in Agriculture & Food Technologies and Business Software.
- Can you name some of Clal Biotechnology Industries' (CBI) notable portfolio companies?
- Clal Biotechnology Industries' (CBI) portfolio includes companies such as TytoCare, which focuses on remote primary care, and Classiq Technologies, a quantum computing software company.
- What is the most recent investment stage Clal Biotechnology Industries (CBI) participated in?
- According to startupim data, Clal Biotechnology Industries (CBI) most recently participated in an investment round in August 2023.
- Has Clal Biotechnology Industries (CBI) had any recent exits?
- Clal Biotechnology Industries (CBI) had an exit in October 2018 when Gamida Cell went public on NASDAQ with a valuation of $210M.
- What is the typical investment stage for Clal Biotechnology Industries (CBI)?
- Clal Biotechnology Industries (CBI) invests in companies ranging from Seed to maturity, including Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round.
- Who is the CEO of Clal Biotechnology Industries (CBI)?
- The CEO of Clal Biotechnology Industries (CBI) is Assaf Segal.
- Where is Clal Biotechnology Industries (CBI) headquartered?
- Clal Biotechnology Industries (CBI) is headquartered in Tel Aviv-Yafo, Israel.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | cbi.co.il |
|---|---|
| linkedin.com/company/16215501 |
Identifiers & details
| Founded | 1993 |
|---|
Radar intelligence
Open jobs — bamboohr
| Total open | 2 |
|---|---|
| Remote | 0 |
| By department | Project (direct) (2) |
| By location | Cambridge, Massachusetts (2) |
| Title | Location | Department |
|---|---|---|
| Senior Associate Facilitator/Mediator (Expression of Interest) | Cambridge, Massachusetts | Project (direct) |
| CBI Internship | Cambridge, Massachusetts | Project (direct) |
Web history (Wayback)
| Domain | cbi.co.il |
|---|
Certificate / subdomain footprint
| Subdomains | 15 |
|---|